GSK Invests $800M in Biologics Facility | Pharma and Biotech Daily

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world.

Today, we're diving into some of the most compelling stories shaping the industry. Let's begin with GSK's bold move to expand its biologics capabilities. The company has announced an $800 million investment in a new biologics production facility and innovation hub in Pennsylvania. This state-of-the-art facility aims to address the increasing demand for biologic...